News & Media: Top News
LATEST NEWS
Exciting things are happening at AVITA Medical. Here is the latest news about our company, products, and pipeline.
PRESS RELEASE | JANUARY 19, 2023
AVITA Medical Announces Management Changes and Fourth Quarter 2022 Earnings Conference Call
PRESS RELEASE | DECEMBER 19, 2022
AVITA Medical Submits FDA PMA Application to Expand Indication to Vitiligo
PRESS RELEASE | DECEMBER 12, 2022
AVITA Medical Announces Results of 2022 Annual Meeting of Stockholders
PRESS RELEASE | DECEMBER 12, 2022
AVITA Medical Submits FDA PMA Supplement to Further Expand Indication to Soft Tissue Repair
PRESS RELEASE | NOVEMBER 21, 2022
AVITA Medical® to Present at the Piper Sandler 34th Annual Healthcare Conference
IN THE NEWS
This article may contain information for uses of our product that are not approved in certain countries or regions.
In the United States, RECELL® is approved for use in patients suffering acute thermal burns. Use of RECELL in other patient populations is either prohibited by United States law or may be made available pursuant to a relevant investigational device exemption granted by the FDA (and likewise limited by United States law to investigational use only) or otherwise prohibited.